Fixed Duration vs Continuous Anti-CD38 Antibody Therapy Among Transplant Ineligible Older Adults With Newly-Diagnosed Multiple Myeloma
Conditions
Multiple Myeloma
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Cross Cancer Institute, Edmonton, Alberta, Canada
Contact: Study coordinator (Steven Shih)BCCA - Kelowna, Kelowna, British Columbia, Canada
BCCA - Vancouver, Vancouver, British Columbia, Canada
Contact: Study coordinator (Christopher Venner)CancerCare Manitoba, Winnipeg, Manitoba, Canada
The Moncton Hospital, Moncton, New Brunswick, Canada
Regional Health Authority B, Zone 2, Saint John, New Brunswick, Canada
Dr. H. Bliss Murphy Cancer Centre, St. John's, Newfoundland and Labrador, Canada
Royal Victoria Regional Health Centre, Barrie, Ontario, Canada
Contact: Study coordinator (Rouslan Kotchetkov)William Osler Health System, Brampton, Ontario, Canada
Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton, Ontario, Canada
Kingston Health Sciences Centre, Kingston, Ontario, Canada
Contact: Study coordinator (Bethany Monteith)Waterloo Regional Health Network (WRHN), Kitchener, Ontario, Canada
London Health Sciences Centre Research Inc., London, Ontario, Canada
Stronach Regional Health Centre at Southlake, Newmarket, Ontario, Canada
Lakeridge Health Oshawa, Oshawa, Ontario, Canada
Ottawa Hospital Research Institute, Ottawa, Ontario, Canada
Algoma District Cancer Program, Sault Ste. Marie, Ontario, Canada
Niagara Health System, St. Catharines, Ontario, Canada
St. Michael's Hospital, Toronto, Ontario, Canada
St. Joseph's Health Centre, Toronto, Ontario, Canada
Contact: Study coordinator (Christie Kim)Windsor Regional Cancer Centre, Windsor, Ontario, Canada
CIUSSS de l'Est-de-I'lle-de-Montreal, Montreal, Quebec, Canada
The Jewish General Hospital, Montreal, Quebec, Canada
St. Mary's Hospital, Montreal, Quebec, Canada
The Research Institute of the McGill University, Montreal, Quebec, Canada
CHU de Quebec-Hopital l'Enfant-Jesus (HEJ), Québec, Quebec, Canada
Allan Blair Cancer Centre, Regina, Saskatchewan, Canada
Saskatoon Cancer Centre, Saskatoon, Saskatchewan, Canada
Study leads
Hira Mian
Study Chair
Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton, Ontario Canada